BSPS Liquid Based Cytology System

The FRIMLEY HEALTH NHS FOUNDATION TRUST, a public authority within the central government sector, is currently in the planning stage of a procurement process for a BSPS Liquid Based Cytology System. This procurement initiative, which revolves around pathology services, is aimed at supporting cytology in the context of cervical cancers. The services are intended to be delivered across multiple regions within the United Kingdom, specifically UKC, UKD, UKE, UKF, UKG, UKH, UKI, UKJ, and UKK.

The contract period is projected to start on 1st August 2026 and conclude on 31st July 2031, with a future notice date slated for 2nd January 2026. This procurement falls under the 'services' category and is initiated based on the UKPGA 2023/54 legal framework. This tender presents substantial opportunities for businesses, particularly those involved in the fields of medical technology and healthcare services, to expand their market presence.

Companies with expertise in pathology and innovative solutions in cytology systems, particularly those focused on cervical cancer diagnostics, would be well-positioned to compete. With the planned deployment across various UK regions, businesses capable of delivering scalable and effective sitology support are likely to find this procurement especially beneficial for growth and diversification of services.